Berit Markevärn
- Hematology top 1%
- Genetics top 2%
- Rheumatology top 5%
- Molecular Biology
- Oncology
- Co-authors
- Leif StenkeJohan RichterMagnus BjörkholmUlla Olsson‐StrömbergMartin HöglundAnders WåhlinMarie NilssonIrina Golovleva
- Topics
- Chronic Myeloid Leukemia Treatments (23 papers)Chronic Lymphocytic Leukemia Research (20 papers)Eosinophilic Disorders and Syndromes (10 papers)
- Cited by
- HematologyGeneticsRheumatology
In The Last Decade
Berit Markevärn
30 papers receiving 784 citations
Peers
Comparison fields: 5 of 44
- Hematology 671
- Genetics 558
- Rheumatology 204
- Molecular Biology 199
- Oncology 154
Countries citing papers authored by Berit Markevärn
This map shows the geographic impact of Berit Markevärn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berit Markevärn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berit Markevärn more than expected).
Fields of papers citing papers by Berit Markevärn
This network shows the impact of papers produced by Berit Markevärn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berit Markevärn. The network helps show where Berit Markevärn may publish in the future.
Co-authorship network of co-authors of Berit Markevärn
This figure shows the co-authorship network connecting the top 25 collaborators of Berit Markevärn. A scholar is included among the top collaborators of Berit Markevärn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Berit Markevärn. Berit Markevärn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 5 | |
| 3 | 16 | |
| 4 | 10 | |
| 5 | 5 | |
| 6 | 25 | |
| 7 | 21 | |
| 8 | 19 | |
| 9 | 49 | |
| 10 | 17 | |
| 11 | 57 | |
| 12 | 174 | |
| 13 | 34 | |
| 14 | 6 | |
| 15 | 4 | |
| 16 | 3 | |
| 17 | 2 | |
| 18 | 19 | |
| 19 | 32 | |
| 20 | 68 |
About Berit Markevärn
Berit Markevärn is a scholar working on Hematology, Genetics and Rheumatology, having authored 30 papers that have together received 796 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (23 papers), Chronic Lymphocytic Leukemia Research (20 papers) and Eosinophilic Disorders and Syndromes (10 papers). The work is most often cited by research in Hematology (671 citations), Genetics (558 citations) and Rheumatology (204 citations). Berit Markevärn has collaborated with scholars based in Sweden, Norway and Finland. Frequent co-authors include Leif Stenke, Johan Richter, Magnus Björkholm, Ulla Olsson‐Strömberg, Martin Höglund, Anders Wåhlin, Marie Nilsson, Irina Golovleva, Arta Dreimane and Jan Samuelsson. Their work appears in journals such as Journal of Clinical Oncology, Blood and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.